Article
Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl.
Pharmacogenetics and genomics - 1 Jan 2005
Rothe Hansjörg M, Shapiro Warren B, Sun Wei Y, Chou Shyan-Yih
Abstract excerpt
Cinacalcet, a novel calcimimetic compound, is effective in reducing parathyroid hormone (PTH) levels in approximately 70% of patients with secondary hyperparathyroidism. However, interindividual variations in the dose required to achieve the treatment goal have been noted in clinical studies. Our investigation examined the genetic polymorphisms of the calcium-sensing receptor (CaSR) gene as one possible cause of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
